Inventor
GLEAVE MARTIN
CA24 patents
⚠️ This page may combine multiple inventors who share the name “GLEAVE MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV BRITISH COLUMBIA
14 patentsUS7732422B2Jun 8, 2010
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA125 citations98
US7368436B2May 6, 2008
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA35 citations95
US7973017B2Jul 5, 2011
Treatment of cancer by inhibition of IGFBP's and clusterin
UNIV BRITISH COLUMBIA9 citations92
US7592323B1Sep 22, 2009
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA14 citations92
US7534773B1May 19, 2009
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA11 citations92
US7285541B2Oct 23, 2007
Treatment of melanoma by reduction in clusterin levels
UNIV BRITISH COLUMBIA18 citations92
US6900187B2May 31, 2005
TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
UNIV BRITISH COLUMBIA37 citations92
US7569551B2Aug 4, 2009
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
UNIV BRITISH COLUMBIA13 citations88
US7196067B2Mar 27, 2007
Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
UNIV BRITISH COLUMBIA13 citations80
US7297684B1Nov 20, 2007
Antisense therapy for hormone-regulated tumors
UNIV BRITISH COLUMBIA6 citations73
US8361981B2Jan 29, 2013
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
UNIV BRITISH COLUMBIA4 citations72
US7550580B2Jun 23, 2009
Compositions and methods for treatment of prostate and other cancers
UNIV BRITISH COLUMBIA2 citations62
US7820635B2Oct 26, 2010
RNAi probes targeting cancer-related proteins
UNIV BRITISH COLUMBIA2 citations60
US8580761B2Nov 12, 2013
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
UNIV BRITISH COLUMBIA0 citations51
GLEAVE MARTIN
10 patentsUS8173615B2May 8, 2012
TRPM-2 antisense therapy
GLEAVE MARTIN7 citations83
US9095602B2Aug 4, 2015
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
GLEAVE MARTIN7 citations82
US8536149B2Sep 17, 2013
TRPM-2 antisense therapy
GLEAVE MARTIN3 citations73
US9101646B2Aug 11, 2015
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
GLEAVE MARTIN1 citations62
US9074209B2Jul 7, 2015
TRPM-2 antisense therapy
GLEAVE MARTIN1 citations62
US8389491B2Mar 5, 2013
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
GLEAVE MARTIN2 citations62
US8772470B1Jul 8, 2014
Compositions and methods for treatment of prostate and other cancers
GLEAVE MARTIN1 citations61
US8168610B2May 1, 2012
Bispecific oligonucleotide for the treatment of CNS malignancies
GLEAVE MARTIN2 citations54
US9487777B2Nov 8, 2016
RNAi probes targeting cancer-related proteins
GLEAVE MARTIN0 citations49
US8759308B2Jun 24, 2014
RNAi probes targeting cancer-related proteins
GLEAVE MARTIN0 citations49